Document Detail


Misoprostol for cervical ripening prior to gynecological transcervical procedures.
MedLine Citation:
PMID:  23241727     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Dilatation and curettage is frequently performed in gynecological practice. Aim of this prospective randomized double-blind placebo-controlled study was to evaluate the safety and efficacy of oral misoprostol to prime non-pregnant cervix before this procedure. METHOD: Women requiring dilatation and curettage were included in the study. Exclusion criteria were visible growth in cervix or vagina, pregnancy, allergy to prostaglandins, some medical disorders. Each participant was instructed to take either 400 µg of misoprostol or placebo orally 12 h before the procedure. Primary outcome measure was: diameter of the largest negotiable Hegar's dilator through internal os without any resistance at the beginning of the procedure. Secondary outcome measures were: percentage of women with initial cervical dilatation of ≥5 mm, time required for optimum cervical dilatation, percentage of failed procedures and complications. t test, Chi-square test and Fisher's test were used to compare the variables. RESULT: Misoprostol significantly increased baseline cervical diameter in the pre-menopausal group (p < 0.001), but not in post-menopausal subjects (p = 0.1) and reduced time required for cervical dilatation in both pre-and post-menopausal women. The number of patients achieving initial cervical dilatation ≥5 mm was significantly greater in pre-menopausal subjects receiving misoprostol, but not significant in post-menopausal ones. The drug was also found to be effective in both nulliparous and multiparous patients. Side effects were comparable between two groups. Only nausea and vomiting were more frequent in post-menopausal misoprostol group than placebo (p = 0.018). CONCLUSION: Four hundred micrograms of oral misoprostol 12 h prior to dilation and curettage was found to be beneficial in cervical priming in pre-menopausal subjects. It was also found to be effective irrespective of the parity of the patients.
Authors:
Anuradha Ghosh; Picklu Chaudhuri
Related Documents :
20102937 - Major adverse cardiac events in patients with moderate to severe renal insufficiency tr...
9313607 - Laser balloon angioplasty combined with local intracoronary heparin therapy: immediate ...
18046527 - Troponin level and efficacy of abciximab in patients with acute coronary syndromes unde...
6233887 - Return to work after coronary angioplasty: a report from the national heart, lung, and ...
17435547 - Enteral vancomycin controls methicillin-resistant staphylococcus aureus endemicity in a...
16860017 - Relation of preprocedural statin therapy to in-hospital procedural complications follow...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-16
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  -     ISSN:  1432-0711     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Gynecology and Obstetrics, Sagar Dutta Medical College and Hospital, Kolkata, India, khooshee@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intraoperative infusion of 0.6-0.9 µg·kg(-1)·min(-1) remifentanil induces acute tolerance in youn...
Next Document:  The association of a cervical length of <25 mm in high-risk pregnancies on neonatal morbidity and m...